Renu Gupta

CIK 1269592 · Executive Vice President & CMO · last filed 2017-05-26

Renu Gupta is an Executive Vice President & CMO who has filed 13 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for CRBP, was dated May 26, 2017. Across all open-market trades the lifetime net is +$31.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.3M across reported positions. 5 SEC filings were submitted jointly with AGENUS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$4.30M
Companies
3
Total Filings
13
Lifetime Open-Market Net
$31.6K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CRBP price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers
AGENUS INC — 5 joint filings, latest 2006-07-24
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRBP Director 333 $3.52 $1.2K $18.9K 4 2017-05-26
INSM Executive Vice President & CMO 37,014 $116.10 $4.30M $0 7 2014-02-04
INSMED Inc (INSMD) Delisted EVP & Chief Medical Officer 2,000 — — $12.7K 1 2011-03-28

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-05-26 CRBP Grant (A) — $0 EDGAR
2016-05-31 CRBP Grant (A) — $0 EDGAR
2015-08-19 CRBP Buy (P) +10,000 $18.9K EDGAR
2015-08-17 CRBP Grant (A) — $0 EDGAR
2014-12-05 — Buy (P) +5,000 $15.0K
2014-02-04 INSM Mixed +17,507 -$212.2K EDGAR
2014-01-14 INSM Grant (A) — $0 EDGAR
2013-07-02 INSM Mixed +17,507 -$124.3K EDGAR
2013-05-28 INSM Grant (A) — $0 EDGAR
2013-03-22 INSM Grant (A) — $0 EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.